Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B study (CALGB 10503)

In this prospective phase 2 clinical trial conducted by Cancer and Leukemia Group B (CALGB, now the Alliance), we studied decitabine as maintenance therapy for younger adults with acute myeloid leukemia (AML) who remained in first complete remission (CR1) following intensive induction and consolidat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Leukemia
Autores principales: Blum, William, Sanford, Ben L., Klisovic, Rebecca, DeAngelo, Daniel J., Uy, Geoffrey, Powell, Bayard L., Stock, Wendy, Baer, Maria R., Kolitz, Jonathan E., Wang, Eunice S., Hoke, Eva, Mrózek, Krzysztof, Kohlschmidt, Jessica, Bloomfield, Clara D., Geyer, Susan, Marcucci, Guido, Stone, Richard M., Larson, Richard A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214595/
https://ncbi.nlm.nih.gov/pubmed/27624549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.252
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares